The Coronavirus pandemic has provided a huge boost to the immunity sector.
What opportunities does this afford to your brand & how do you explore them?
In this complimentary webinar we will discuss some of the insights and consider the methods to help you understand consumer attitudes, behaviours and needs arising from Covid-19. We will also cover the range of ingredients being promoted for immune support and how to ensure that your product meets claims over shelf life.
This webinar will consider:
• How you appraise what is understood and not understood about immunity and its relevance to identify new opportunities for your business
• How opportunities can be worked up into an actionable set of design guidelines for NPD
• The ingredients linked to immune health and examples of product launches in this space
• Novel ways of assessing ingredients and their role in promoting the immunity message
• How RSSL can support your NPD and permitted claim substantiation
• Natural vs synthetic – the impact on immunity effectiveness and analytical requirements
What opportunities does this afford to your brand & how do you explore them?
In this complimentary webinar we will discuss some of the insights and consider the methods to help you understand consumer attitudes, behaviours and needs arising from Covid-19. We will also cover the range of ingredients being promoted for immune support and how to ensure that your product meets claims over shelf life.
This webinar will consider:
• How you appraise what is understood and not understood about immunity and its relevance to identify new opportunities for your business
• How opportunities can be worked up into an actionable set of design guidelines for NPD
• The ingredients linked to immune health and examples of product launches in this space
• Novel ways of assessing ingredients and their role in promoting the immunity message
• How RSSL can support your NPD and permitted claim substantiation
• Natural vs synthetic – the impact on immunity effectiveness and analytical requirements
